Tirzepatide, a dual GLP-1 and GIP receptor agonist, slows stomach emptying to reduce hunger and increase fullnessbut this same mechanism often triggers burping, bloating, and gas in the first month of treatment
This dual mechanismrapid weight loss combined with potential direct effects on gallbladder functionmay explain the observed association between GLP-1 therapy and gallstone risk
Anti-inflammatory NF-B Modulation MC1R and MC3R activation by melanocortin peptides has been shown to suppress NF-B nuclear translocation and downregulate pro-inflammatory cytokine production (TNF-, IL-6, IL-1) in macrophage and keratinocyte models, suggesting a role in cutaneous inflammatory signaling research (Luger et al., Journal of Investigative Dermatology, 1997)
This removal process is important, as hydrogen peroxide is a reactive oxygen species, which causes oxidative damage and inflammation
Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study